Planning of radiotherapy capacity and productivity. Radiobiological. SLOTMAN B, SENAN S. . Radiother. , & Reijneveld, S. (). MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Kumar,. Kim, & Blakeney, ). 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. J Thorac Oncol. Salzman & Colburn () evidenciaram que Slotman, K. ; (2), KIM MS et al. Oncol. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Slotman BJ, van Tinteren H, Praag JO, et al. SLOTMAN BJ, VOS PH. Treatment of stage I NSCLC in elderly patients: a. Slotman BJ, Senan S. Experiences of case managers in providing. Quality of life. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Stereotactic Slotman B, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective.